Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.

about

Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.

Item

http://www.wikidata.org/entity/Q49909927

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@en

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@nl

type

Item

label

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@en

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@nl

prefLabel

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@en

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@nl

P1476

Cardio-oncology: conflicting p ...... nt and cardiovascular outcome.

@en

P2093

Hugo A Katus

http://www.w3.org/2001/XMLSchema#string

Lisa M Tilemann

http://www.w3.org/2001/XMLSchema#string

Markus B Heckmann

http://www.w3.org/2001/XMLSchema#string

Oliver J Müller

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL

Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study.

Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis

Early and late arrhythmogenic effects of doxorubicin.

Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.

American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants.

Low-molecular-weight heparin versus placebo for the prevention of venous thromboembolism in metastatic breast cancer or stage III/IV lung cancer.

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

P2888

s00392-018-1202-x

P304

271-280

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00392-018-1202-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Lorenz H Lehmann

P5008

ScienceSource

P577

2018-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29453595

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

cardiovascular disease

P932

5869944

http://www.w3.org/2001/XMLSchema#string